Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis

British Journal of Rheumatology

Volumn 36, Issue 2, 1997, Pages 255-259

  Adachi, J D ^a,b   Bensen, W G ^a   Bell, M J ^a   Bianchi, F A ^a   Cividino, A A ^a   Craig, G L ^a   Sturtridge, W C ^a   Sebaldt, R J ^a   Steele, M ^a   Gordon, M ^a   Themeles, E ^a   Tugwell, P ^a   Roberts, R ^a   Gent, M ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

Corticosteroids; Nasal calcitonin; Osteoporosis

Indexed keywords

BENZALKONIUM CHLORIDE; CORTICOSTEROID; DRUG VEHICLE; HYDROCHLORIC ACID; PREDNISONE; SALCATONIN; SODIUM CHLORIDE;

AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA; STEROID THERAPY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 0347053164     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.255     Document Type: Article

References (12)

1. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
2. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
3. Ringe JD, Welzel D. Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 1987;33:35-9.
4. Luengo M, Picado C, Del Rio L, Guanebens N, Montserrat JM, Setoain J. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. Am Rev Respir Dis 1990;142:104-7.
5. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991;49:71-6.
6. Sambrook PN, Birmingham J, Kelly PJ, Kempler S, Pocock NA, Eisman JA. Prevention of corticosteroid osteoporosis; a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.
7. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443-53.
8. Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987;ii:1481-3.
9. Overgaard K, Riis BJ, Christiansen C, Podenphant J, Johansen JS. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 1989;30:435-42.
10. Overgaard K, Christiansen C. Long-term treatment of established osteoporosis with intranasal calcitonin. Calcif Tissue Int 1991;49:S60-3.
11. Reginster JY, Meurmans L, Deroisy R et al. A 5-year controlled randomized study of prevention of post-menopausal trabecular bone loss with nasal salmon calcitonin and calcium. Eur J Clin Invest 1994;24:565-9.
12. Gennari C, Agnusdei D, Montagnani M et al. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss. Calcif Tissue Int 1992;50:381-3.